Hal Andrews News Today

Trilliant Health, the leading provider of data-driven strategy analytics for the health economy, announced the launch of Network Explorer, a…

Most hospitals and payers have publicly posted their pricing information, but experts think that data will remain mostly useless for consumers for at least another five years. Now that the data is available, healthcare software companies must step in and build tools that are personalized and easy to use. That way, consumers can eventually use price transparency data to shop for care.

Despite Cigna and Humana ditching their pursuits to combine in December, one industry expert believes there's still a chance after Cigna announced its plan to sell its Medicare Advantage business to Health Care Service Corp.

I didn’t make it to this year’s J.P. Morgan Healthcare Conference in San Francisco, so I reached out to leaders from across the industry to hear how it went and learn about their takeaways from the event. This is a list of the nine most interesting responses that I received.

On New Year’s Day, two Missouri health systems — St. Louis-based BJC HealthCare and Kansas City-based St. Luke’s Health System — officially completed their merger. The combined health system comprises 28 hospitals and hundreds of clinics serving 6 million people, and it is expected to generate $10 billion in annual revenue.

Will General Catalyst’s plans for health system acquisition come to fruition in 2024? Will GenAI live up to its hype as healthcare’s ultimate complexity liberator?

Trilliant Health, the healthcare industry’s leading analytics firm, today released its Market Explorer…

AbbVie announced plans to acquire Immunogen — and the biotech’s recently approved ADC treatment for ovarian cancer — for $10.1 billion in cash. The pharma giant is diving into ADCs again after a previous multibillion-dollar acquisition of a different ADC drugmaker ended up failing a few years ago.

The directory contains information on more than 2.7 million providers nationwide with over 65 million data points.

Administration officials are expected to unveil the list<b> </b>before stock markets open Tuesday since it could affect public drug companies’ stock prices.